Acute heart failure with preserved ejection fraction: unique patient characteristics and targets for therapy.
Acute heart failure with preserved ejection fraction: unique patient characteristics and targets for therapy.
复制标题
DOI：
10.1007/s11897-013-0149-5
复制
发表时间：
2013-09-01
影响因子：
--
通讯作者：
Redfield, Margaret M
中科院分区：
文献类型：
--
作者：
Bishu, Kalkidan;Redfield, Margaret M
目前，每年有100万人因急性心力衰竭（AHF）出院。预计到2030年，美国心力衰竭（HF）治疗的总成本将增加至530亿美元，其中大部分成本（80%）与AHF住院治疗有关。大约50%的AHF发作发生在射血分数保留（HFpEF）患者中。在HFpEF患者中，缺乏管理AHF的循证指南。在这里，我们简要回顾流行病学，病理生理学，和治疗的AHF患者HFpEF。
Currently, there are 1.0 million annual hospital discharges for acute heart failure (AHF). The total cost of heart failure (HF) care in the United States is projected to increase to $53 billion in 2030, with the majority of costs (80 %) related to AHF hospitalizations. Approximately 50 % of AHF episodes occur in patients with preserved ejection fraction (HFpEF). There is a dearth of evidence-based guidelines for the management of AHF in HFpEF patients. Here, we briefly review the epidemiology, pathophysiology, and treatment of AHF patients with HFpEF.